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CASE REPORT
The gene responsible for nail-patella syndrome, LMX1B, has recently been identified on chromosome 9q. Here
we present a patient with nail-patella syndrome and an autosomal dominant pattern of inheritance. A 17-year-old
girl visited our clinic for the evaluation and treatment of proteinuria. She had dystrophic nails, palpable iliac horns,
and hypoplastic patellae. Electron microscopy of a renal biopsy showed irregular thickening of the glomerular
basement membrane. A family history over three generations revealed five affected family members. Genetic
analysis found a change of TCG to TCC, resulting in a synonymous alteration at codon 219 in exon 4 of the
LMX1B gene in two affected family members. The same alteration was not detected in an unaffected family
member. This is the first report of familial nail-patella syndrome associated with an LMX1B in Korea mutation,
However, we can not completely rule out the possibility that the G-to-C change may be a single nucleotide
polymorphism as this genetic mutation cause no alteration in amino acid sequence of LMX1B. (Korean J Intern
Med 2009;24:274-278)
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INTRODUCTION
Nail-patella syndrome (NPS) is a highly penetrant,
autosomal-dominant hereditary disorder that exhibits
variable expression within and among families. The
condition is pleiotropic and affects tissues of both
ectodermal and mesodermal origin. Manifestations
include symmetrical nail, skeletal, ocular, and renal
anomalies [1]. Triangular lunulae at the base of the nails
and longitudinal nail ridges are characteristic of NPS.
Skeletal abnormalities include absent or hypoplastic
patellae, triangular bony protuberances of the posterior
ilium (iliac horns), and contractures of other joints [2,3].
Nephropathy manifests with proteinuria or intermittent
nephritic syndrome; in 8-10% of cases, renal problems
will progress to renal failure and can be a serious com-
plication in some families [4,5]. Recent evidence suggests
that open-angle glaucoma may also be part of the syndrome
[6]. 
Linkage studies have refined the location of the NPS
gene to a 1-2 cM interval at 9q34, and a LIM-homeodomain
gene, LMX1B, has been mapped to the same general
location [7]. This disorder has recently been shown to be
caused by heterozygous loss-of-function mutations in the
LIM-homeodomain transcription factor (LMX1B), which
is required for the normal development of dorsal limb
structure, the glomerular basement membrane, the anterior
segment of the eye, and dopaminergic and serotonergic
neurons. Although to date no obvious correlation has been
established between LMX1B mutations and the range andHam JH, et al. LMX1B gene mutation in nail-patella syndrome    275
severity of NPS symptoms, many studies continue to
identify associations between clinical features and a
variety of LMX1B mutations. These efforts allow the
examination of interactions between LMX1B and other
factors that regulate development of the human limb, eye,
and nervous system. 
No studies have previously reported mutation analyses
of NPS in Korean patients. In this report, we present the
identification of a genetic alteration in the LMX1B gene
found in a Korean family with NPS. 
CASE REPORT
The family history revealed no known consanguinity
among the patients, who reside in different regions of
Korea (Fig. 1). The pedigree constructed comprises seven
members of three generations. Summaries of physical
findings for each member at the time of genetic testing are
presented in Table 1. Five affected members were identified:
one on the basis of anamnestic data (probable disease)
and four after reviews of medical records and physical
examinations (diagnosed disease). All three generations
evaluated had family members with NPS. 
The proband (III-2) was referred for nephrological
assessment due to proteinuria. Physical examination
showed nail changes, including spooning, roughening of
the nail plate, longitudinal ridges, and hypoplasia of the
midportion of the nails, which were prominent on the
thumbs and index fingers (Fig. 2A); decreased range of
movement at the elbows with mild antecubital webbing; a
restricted range of motion (from 0˚ to 135˚) with some
crepitation in both knees, and laterally subluxed patellae;
and palpable posterior iliac horns. Standard radiographs
of the elbow revealed hypoplasia of the radial epiphysis;
in addition, mediolateral radiographs of the knee joint
showed that both patellae were hypoplastic. Pelvic radio-
graphy confirmed the presence of bilateral posterior iliac
horns (Fig. 2B). On ophthalmologic examination, the
patient excretion had open-angle glaucoma and trabecu-
lodysgenesis. Urinalysis showed 3+ proteinuria, and 24-
hour urine protein was elevated 476 mg/ 24 hours. Blood
urea nitrogen and serum creatinine were both normal.
On renal biopsy, the glomeruli appeared normal under
light microscopy, and immunofluorescence microscopy
was negative for immunoglobulin, complement components,
and fibrinogen. Electron microscopy revealed prominent
thickening of the glomerular basement membrane, with
irregular, sharply defined rarefied areas, which gave rise
to a pathognomonic “moth-eaten” appearance. After
phosphotungstic acid staining, dark fibrillar collagen
bundles were observed within the rarefied areas of the
glomerular basement membrane (Fig. 3). 
Genetic findings
After obtaining written informed consent, we performed
a genetic analysis of three members of the family shown in
Fig. 1. DNA from two affected individuals (II-2, III-2) and
an unaffected family member (II-1) were analyzed for the
presence of LMX1B mutations. The other two affected
Figure 1. Simplified pedigree of a family with NPS. Circles
indicate women, squares denote men, and black symbols
represent the affected individuals; diagonal lines across
symbols specify deceased indivisuals; the arrow indicates the
proband.
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Table 1. Summary of clinical features of patients with nail-patella syndrome
Affected Nail hypoplasia/ Patella Elbow Iliac Eye Nephropathy
individuals dysplasia hypoplasia hypoplasia horns abnormality
I-2 + Unknown Unknown Unknown Unknown Unknown
II-2 + + - + + +
II-3 + + - + Unknown +
III-1 + + + + Unknown +
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members (II-3 and III-1) refused genetic analysis. 
Genomic DNA was isolated from blood leukocytes using
a QIAamp DNA Blood Mini Kit (Qiagen, Hilden,
Germany). The region encoding eight exons of the LMX1B
gene was amplified from the genomic DNA by polymerase
chain reaction (PCR) using a previously described primer
pair [8]. Subsequently, PCR products were sequenced
using an ABI Prism BigDye Terminator Cycle Sequencing
Ready Reaction Kit (PE Applied Biosystems, Foster City,
CA, USA) and the forward and reverse primers from the
PCR amplification. The sequencing was performed on an
ABI 3700 automated sequencer (PE Applied Biosystems).
Data were collected and analyzed using the ABI DNA
sequence analysis software (version 3.6; PE Applied
Biosystems, Foster City, CA, USA). 
DNA analysis of the patients (III-2, II-2) showed a
Figure 2. Patient with nail-patella syndrome showing (A) a dystrophic nail with longitudinal ridging and (B) bilateral iliac horns
(arrows).
A B
Figure 3. Electron micrographs of renal biopsy (proband III-2) with nail-patella syndrome. (A) The glomerular basement membrane
shows prominent segmental thickening with irregularly shaped electron-lucent areas (uranyl acetate-lead citrate, ×17,000). (B) Dark
fibrillar collagen bundles are located within the electron-lucent areas of the glomerular basement membrane (phosphotungstic acid,
×30,000).
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single-nucleotide change of TCG to TCC, resulting in a
synonymous alteration at codon 219 in exon 4 of the
LMX1B gene (Fig. 4A). No other abnormalities were found
in the exons analyzed. The same alteration was not
detected in one patient’s unaffected uncle (II-1; Fig. 4B).
DISCUSSION
Conformational changes in the LMX1B gene would be
expected to result in the dysfunction of normal patterning
in the dorsoventral axis of the limb and in early morpho-
genesis of the glomerular basement membrane. A synony-
mous alteration, TCG to TCC at codon 219 in exon 4 of the
LMX1B gene, was identified in a Korean family with NPS.
Serine is translated from codon TCG or TCC. At this codon,
this same mutation has been previously identified in
familial NPS cases, resulting in no amino acid change [1]. 
Human NPS mutations are present predominantly in
exon 2 and to a lesser extent in exons 3, 4, 5, and 6 (85%),
and include single-base substitutions (missense, splice
site, nonsense, or frameshift mutations) and deletions or
insertions [9]. The other 15% of mutations presumably lie
deep within introns or involve deletion of all or part of the
gene. The presence of these latter mutations most likely
leads to a severe reduction in the levels of mutant transcript
compared to normal alleles, which would result in very
little, if any, synthesis of abnormal proteins [10]. Recent
reports show that synonymous substitutions are not
pathogenic mutations, based on sequencing over 200
unrelated individuals [11]. In addition, this single allelic
nucleotide, TC [G/C] in codon 219, has been reported to
have a high frequency of heterozygosity (0.46) in the
general population. Therefore, a pathogenic role for this
silent mutation, TCG to TC [G/C] in the LMX1B gene,
remains to be defined. A possible explanation of the
observed phenomenon is that epigenetic silencing can be
a mechanism of disease development in patients without
Figure 4. Automated sequence anlaysis of exon 4 from the LMX1b gene. (A) The panel showed the synonymous G-to-C alteration. In
addition, it showed a G-to-C transition that result in no amino acid change (arrow). (B) The results founded in affected patients is not
shown in unaffected family member. Green lines, adenosine residues (A); blue lines, cytosine (C); black lines, guanine (G); redlines,
thymine (T).
G
216 Glu 217 Val 218 Ser 219 Ser 220 Lys 221 Pro 222 Cys
GG G G G G
C
TT T T T CC C C C C AA A
G
216 Glu 217 Val 218 Ser 219 Ser 220 Lys 221 Pro 222 Cys
GG G G G G TT T T T CC C C C C AA A
A
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genetic abnormality. In addition, the possibility of an
alternation at the protein level cannot be excluded [12,13].
We could not, however, demonstrate any segregation of
this synonymous mutation with the disease. In addition,
we did not conduct functional analyses of mutant proteins
detected in the patients to elucidate either the transcrip-
tional or the DNA-binding activity of these mutant proteins.
Therefore, care should be taken when interpreting the
results of this study, as the possibility cannot be ruled out
that the G-to-C change, which is silent, is a single-nucleotide
polymorphism.  
Although many studies continue to identify mutations
in patients with NPS, no obvious correlation is found
between the presence and severity of clinical features of
NPS and the type or location of known LMX1B mutations.
In the five patients with NPS discussed in this report,
clinical manifestations among the affected members and
the severity of their symptoms were variable. Additional
genetic studies in large, clinically well characterized
families with NPS are necessary to evaluate the possible
influence of modifying alleles on phenotypic expression
and variability. 
In this report, we presented a patient with NPS, charac-
terized by nail dystrophy, iliac horns, open-angle glaucoma,
and nephropathy. DNA analysis of the patient showed a
synonymous alteration of TCG to TCC in exon 4 of the
LMX1B gene, with no alteration in amino acid sequence. 
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